Pharma & Healthcare

Global Tumor Treatment Drug Market Insights, Forecast to 2030

Tumor is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
Market Analysis and Insights: Global Tumor Treatment Drug Market
The global Tumor Treatment Drug market is projected to grow from US$ 1744 million in 2024 to US$ 2473.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Tumor Treatment Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tumor Treatment Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Tumor Treatment Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tumor Treatment Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Tumor Treatment Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Tumor Treatment Drug revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Tumor Treatment Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Treatment Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Treatment Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Treatment Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tumor Treatment Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Treatment Drug Market Perspective (2019-2030)
2.2 Global Tumor Treatment Drug Growth Trends by Region
2.2.1 Tumor Treatment Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tumor Treatment Drug Historic Market Size by Region (2019-2024)
2.2.3 Tumor Treatment Drug Forecasted Market Size by Region (2025-2030)
2.3 Tumor Treatment Drug Market Dynamics
2.3.1 Tumor Treatment Drug Industry Trends
2.3.2 Tumor Treatment Drug Market Drivers
2.3.3 Tumor Treatment Drug Market Challenges
2.3.4 Tumor Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Tumor Treatment Drug by Players
3.1.1 Global Tumor Treatment Drug Revenue by Players (2019-2024)
3.1.2 Global Tumor Treatment Drug Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Tumor Treatment Drug, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Tumor Treatment Drug Market Concentration Ratio
3.4.1 Global Tumor Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Treatment Drug Revenue in 2023
3.5 Global Key Players of Tumor Treatment Drug Head office and Area Served
3.6 Global Key Players of Tumor Treatment Drug, Product and Application
3.7 Global Key Players of Tumor Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Treatment Drug Breakdown Data by Type
4.1 Global Tumor Treatment Drug Historic Market Size by Type (2019-2024)
4.2 Global Tumor Treatment Drug Forecasted Market Size by Type (2025-2030)
5 Tumor Treatment Drug Breakdown Data by Application
5.1 Global Tumor Treatment Drug Historic Market Size by Application (2019-2024)
5.2 Global Tumor Treatment Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tumor Treatment Drug Market Size (2019-2030)
6.2 North America Tumor Treatment Drug Market Size by Type
6.2.1 North America Tumor Treatment Drug Market Size by Type (2019-2024)
6.2.2 North America Tumor Treatment Drug Market Size by Type (2025-2030)
6.2.3 North America Tumor Treatment Drug Market Share by Type (2019-2030)
6.3 North America Tumor Treatment Drug Market Size by Application
6.3.1 North America Tumor Treatment Drug Market Size by Application (2019-2024)
6.3.2 North America Tumor Treatment Drug Market Size by Application (2025-2030)
6.3.3 North America Tumor Treatment Drug Market Share by Application (2019-2030)
6.4 North America Tumor Treatment Drug Market Size by Country
6.4.1 North America Tumor Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Tumor Treatment Drug Market Size by Country (2019-2024)
6.4.3 North America Tumor Treatment Drug Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Tumor Treatment Drug Market Size (2019-2030)
7.2 Europe Tumor Treatment Drug Market Size by Type
7.2.1 Europe Tumor Treatment Drug Market Size by Type (2019-2024)
7.2.2 Europe Tumor Treatment Drug Market Size by Type (2025-2030)
7.2.3 Europe Tumor Treatment Drug Market Share by Type (2019-2030)
7.3 Europe Tumor Treatment Drug Market Size by Application
7.3.1 Europe Tumor Treatment Drug Market Size by Application (2019-2024)
7.3.2 Europe Tumor Treatment Drug Market Size by Application (2025-2030)
7.3.3 Europe Tumor Treatment Drug Market Share by Application (2019-2030)
7.4 Europe Tumor Treatment Drug Market Size by Country
7.4.1 Europe Tumor Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Tumor Treatment Drug Market Size by Country (2019-2024)
7.4.3 Europe Tumor Treatment Drug Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Tumor Treatment Drug Market Size (2019-2030)
8.2 China Tumor Treatment Drug Market Size by Type
8.2.1 China Tumor Treatment Drug Market Size by Type (2019-2024)
8.2.2 China Tumor Treatment Drug Market Size by Type (2025-2030)
8.2.3 China Tumor Treatment Drug Market Share by Type (2019-2030)
8.3 China Tumor Treatment Drug Market Size by Application
8.3.1 China Tumor Treatment Drug Market Size by Application (2019-2024)
8.3.2 China Tumor Treatment Drug Market Size by Application (2025-2030)
8.3.3 China Tumor Treatment Drug Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Tumor Treatment Drug Market Size (2019-2030)
9.2 Asia Tumor Treatment Drug Market Size by Type
9.2.1 Asia Tumor Treatment Drug Market Size by Type (2019-2024)
9.2.2 Asia Tumor Treatment Drug Market Size by Type (2025-2030)
9.2.3 Asia Tumor Treatment Drug Market Share by Type (2019-2030)
9.3 Asia Tumor Treatment Drug Market Size by Application
9.3.1 Asia Tumor Treatment Drug Market Size by Application (2019-2024)
9.3.2 Asia Tumor Treatment Drug Market Size by Application (2025-2030)
9.3.3 Asia Tumor Treatment Drug Market Share by Application (2019-2030)
9.4 Asia Tumor Treatment Drug Market Size by Region
9.4.1 Asia Tumor Treatment Drug Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Tumor Treatment Drug Market Size by Region (2019-2024)
9.4.3 Asia Tumor Treatment Drug Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Tumor Treatment Drug Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Tumor Treatment Drug Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Tumor Treatment Drug Introduction
11.1.4 Roche Revenue in Tumor Treatment Drug Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Tumor Treatment Drug Introduction
11.2.4 Celgene Revenue in Tumor Treatment Drug Business (2019-2024)
11.2.5 Celgene Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Tumor Treatment Drug Introduction
11.3.4 Novartis Revenue in Tumor Treatment Drug Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Tumor Treatment Drug Introduction
11.4.4 Bristol-Myers Squibb Revenue in Tumor Treatment Drug Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Tumor Treatment Drug Introduction
11.5.4 Johnson & Johnson Revenue in Tumor Treatment Drug Business (2019-2024)
11.5.5 Johnson & Johnson Recent Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Tumor Treatment Drug Introduction
11.6.4 Merck & Co. Revenue in Tumor Treatment Drug Business (2019-2024)
11.6.5 Merck & Co. Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Tumor Treatment Drug Introduction
11.7.4 AstraZeneca Revenue in Tumor Treatment Drug Business (2019-2024)
11.7.5 AstraZeneca Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Tumor Treatment Drug Introduction
11.8.4 Pfizer Revenue in Tumor Treatment Drug Business (2019-2024)
11.8.5 Pfizer Recent Developments
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Tumor Treatment Drug Introduction
11.9.4 Amgen Revenue in Tumor Treatment Drug Business (2019-2024)
11.9.5 Amgen Recent Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Tumor Treatment Drug Introduction
11.10.4 Eli Lilly Revenue in Tumor Treatment Drug Business (2019-2024)
11.10.5 Eli Lilly Recent Developments
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Tumor Treatment Drug Introduction
11.11.4 AbbVie Revenue in Tumor Treatment Drug Business (2019-2024)
11.11.5 AbbVie Recent Developments
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Tumor Treatment Drug Introduction
11.12.4 Takeda Revenue in Tumor Treatment Drug Business (2019-2024)
11.12.5 Takeda Recent Developments
11.13 Astellas
11.13.1 Astellas Company Details
11.13.2 Astellas Business Overview
11.13.3 Astellas Tumor Treatment Drug Introduction
11.13.4 Astellas Revenue in Tumor Treatment Drug Business (2019-2024)
11.13.5 Astellas Recent Developments
11.14 Ipsen
11.14.1 Ipsen Company Details
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Tumor Treatment Drug Introduction
11.14.4 Ipsen Revenue in Tumor Treatment Drug Business (2019-2024)
11.14.5 Ipsen Recent Developments
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Tumor Treatment Drug Introduction
11.15.4 Sanofi Revenue in Tumor Treatment Drug Business (2019-2024)
11.15.5 Sanofi Recent Developments
11.16 Bayer
11.16.1 Bayer Company Details
11.16.2 Bayer Business Overview
11.16.3 Bayer Tumor Treatment Drug Introduction
11.16.4 Bayer Revenue in Tumor Treatment Drug Business (2019-2024)
11.16.5 Bayer Recent Developments
11.17 Biogen Idec
11.17.1 Biogen Idec Company Details
11.17.2 Biogen Idec Business Overview
11.17.3 Biogen Idec Tumor Treatment Drug Introduction
11.17.4 Biogen Idec Revenue in Tumor Treatment Drug Business (2019-2024)
11.17.5 Biogen Idec Recent Developments
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Tumor Treatment Drug Introduction
11.18.4 Teva Revenue in Tumor Treatment Drug Business (2019-2024)
11.18.5 Teva Recent Developments
11.19 Otsuka
11.19.1 Otsuka Company Details
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Tumor Treatment Drug Introduction
11.19.4 Otsuka Revenue in Tumor Treatment Drug Business (2019-2024)
11.19.5 Otsuka Recent Developments
11.20 Eisai
11.20.1 Eisai Company Details
11.20.2 Eisai Business Overview
11.20.3 Eisai Tumor Treatment Drug Introduction
11.20.4 Eisai Revenue in Tumor Treatment Drug Business (2019-2024)
11.20.5 Eisai Recent Developments
11.21 Merck KGaA
11.21.1 Merck KGaA Company Details
11.21.2 Merck KGaA Business Overview
11.21.3 Merck KGaA Tumor Treatment Drug Introduction
11.21.4 Merck KGaA Revenue in Tumor Treatment Drug Business (2019-2024)
11.21.5 Merck KGaA Recent Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Details
11.22.2 Gilead Sciences Business Overview
11.22.3 Gilead Sciences Tumor Treatment Drug Introduction
11.22.4 Gilead Sciences Revenue in Tumor Treatment Drug Business (2019-2024)
11.22.5 Gilead Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Tumor Treatment Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Immunotherapy (Biologic Therapy)
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Others
Table 7. Global Tumor Treatment Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Global Tumor Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Tumor Treatment Drug Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Tumor Treatment Drug Market Share by Region (2019-2024)
Table 11. Global Tumor Treatment Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Tumor Treatment Drug Market Share by Region (2025-2030)
Table 13. Tumor Treatment Drug Market Trends
Table 14. Tumor Treatment Drug Market Drivers
Table 15. Tumor Treatment Drug Market Challenges
Table 16. Tumor Treatment Drug Market Restraints
Table 17. Global Tumor Treatment Drug Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Tumor Treatment Drug Revenue Share by Players (2019-2024)
Table 19. Global Top Tumor Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Treatment Drug as of 2023)
Table 20. Global Tumor Treatment Drug Industry Ranking 2022 VS 2023 VS 2024
Table 21. Global 5 Largest Players Market Share by Tumor Treatment Drug Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Tumor Treatment Drug, Headquarters and Area Served
Table 23. Global Key Players of Tumor Treatment Drug, Product and Application
Table 24. Global Key Players of Tumor Treatment Drug, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tumor Treatment Drug Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Tumor Treatment Drug Revenue Market Share by Type (2019-2024)
Table 28. Global Tumor Treatment Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Tumor Treatment Drug Revenue Market Share by Type (2025-2030)
Table 30. Global Tumor Treatment Drug Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Tumor Treatment Drug Revenue Share by Application (2019-2024)
Table 32. Global Tumor Treatment Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Tumor Treatment Drug Revenue Share by Application (2025-2030)
Table 34. North America Tumor Treatment Drug Market Size by Type (2019-2024) & (US$ Million)
Table 35. North America Tumor Treatment Drug Market Size by Type (2025-2030) & (US$ Million)
Table 36. North America Tumor Treatment Drug Market Size by Application (2019-2024) & (US$ Million)
Table 37. North America Tumor Treatment Drug Market Size by Application (2025-2030) & (US$ Million)
Table 38. North America Tumor Treatment Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America Tumor Treatment Drug Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America Tumor Treatment Drug Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe Tumor Treatment Drug Market Size by Type (2019-2024) & (US$ Million)
Table 42. Europe Tumor Treatment Drug Market Size by Type (2025-2030) & (US$ Million)
Table 43. Europe Tumor Treatment Drug Market Size by Application (2019-2024) & (US$ Million)
Table 44. Europe Tumor Treatment Drug Market Size by Application (2025-2030) & (US$ Million)
Table 45. Europe Tumor Treatment Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Europe Tumor Treatment Drug Market Size by Country (2019-2024) & (US$ Million)
Table 47. Europe Tumor Treatment Drug Market Size by Country (2025-2030) & (US$ Million)
Table 48. China Tumor Treatment Drug Market Size by Type (2019-2024) & (US$ Million)
Table 49. China Tumor Treatment Drug Market Size by Type (2025-2030) & (US$ Million)
Table 50. China Tumor Treatment Drug Market Size by Application (2019-2024) & (US$ Million)
Table 51. China Tumor Treatment Drug Market Size by Application (2025-2030) & (US$ Million)
Table 52. Asia Tumor Treatment Drug Market Size by Type (2019-2024) & (US$ Million)
Table 53. Asia Tumor Treatment Drug Market Size by Type (2025-2030) & (US$ Million)
Table 54. Asia Tumor Treatment Drug Market Size by Application (2019-2024) & (US$ Million)
Table 55. Asia Tumor Treatment Drug Market Size by Application (2025-2030) & (US$ Million)
Table 56. Asia Tumor Treatment Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 57. Asia Tumor Treatment Drug Market Size by Region (2019-2024) & (US$ Million)
Table 58. Asia Tumor Treatment Drug Market Size by Region (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Type (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Type (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Application (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Application (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Tumor Treatment Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 64. Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Country (2019-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Tumor Treatment Drug Market Size by Country (2025-2030) & (US$ Million)
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Tumor Treatment Drug Product
Table 69. Roche Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 70. Roche Recent Developments
Table 71. Celgene Company Details
Table 72. Celgene Business Overview
Table 73. Celgene Tumor Treatment Drug Product
Table 74. Celgene Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 75. Celgene Recent Developments
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Tumor Treatment Drug Product
Table 79. Novartis Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 80. Novartis Recent Developments
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Tumor Treatment Drug Product
Table 84. Bristol-Myers Squibb Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Developments
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Tumor Treatment Drug Product
Table 89. Johnson & Johnson Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 90. Johnson & Johnson Recent Developments
Table 91. Merck & Co. Company Details
Table 92. Merck & Co. Business Overview
Table 93. Merck & Co. Tumor Treatment Drug Product
Table 94. Merck & Co. Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 95. Merck & Co. Recent Developments
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Tumor Treatment Drug Product
Table 99. AstraZeneca Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 100. AstraZeneca Recent Developments
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Tumor Treatment Drug Product
Table 104. Pfizer Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 105. Pfizer Recent Developments
Table 106. Amgen Company Details
Table 107. Amgen Business Overview
Table 108. Amgen Tumor Treatment Drug Product
Table 109. Amgen Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 110. Amgen Recent Developments
Table 111. Eli Lilly Company Details
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Tumor Treatment Drug Product
Table 114. Eli Lilly Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 115. Eli Lilly Recent Developments
Table 116. AbbVie Company Details
Table 117. AbbVie Business Overview
Table 118. AbbVie Tumor Treatment Drug Product
Table 119. AbbVie Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 120. AbbVie Recent Developments
Table 121. Takeda Company Details
Table 122. Takeda Business Overview
Table 123. Takeda Tumor Treatment Drug Product
Table 124. Takeda Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 125. Takeda Recent Developments
Table 126. Astellas Company Details
Table 127. Astellas Business Overview
Table 128. Astellas Tumor Treatment Drug Product
Table 129. Astellas Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 130. Astellas Recent Developments
Table 131. Ipsen Company Details
Table 132. Ipsen Business Overview
Table 133. Ipsen Tumor Treatment Drug Product
Table 134. Ipsen Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 135. Ipsen Recent Developments
Table 136. Sanofi Company Details
Table 137. Sanofi Business Overview
Table 138. Sanofi Tumor Treatment Drug Product
Table 139. Sanofi Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 140. Sanofi Recent Developments
Table 141. Bayer Company Details
Table 142. Bayer Business Overview
Table 143. Bayer Tumor Treatment Drug Product
Table 144. Bayer Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 145. Bayer Recent Developments
Table 146. Biogen Idec Company Details
Table 147. Biogen Idec Business Overview
Table 148. Biogen Idec Tumor Treatment Drug Product
Table 149. Biogen Idec Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 150. Biogen Idec Recent Developments
Table 151. Teva Company Details
Table 152. Teva Business Overview
Table 153. Teva Tumor Treatment Drug Product
Table 154. Teva Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 155. Teva Recent Developments
Table 156. Otsuka Company Details
Table 157. Otsuka Business Overview
Table 158. Otsuka Tumor Treatment Drug Product
Table 159. Otsuka Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 160. Otsuka Recent Developments
Table 161. Eisai Company Details
Table 162. Eisai Business Overview
Table 163. Eisai Tumor Treatment Drug Product
Table 164. Eisai Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 165. Eisai Recent Developments
Table 166. Merck KGaA Company Details
Table 167. Merck KGaA Business Overview
Table 168. Merck KGaA Tumor Treatment Drug Product
Table 169. Merck KGaA Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 170. Merck KGaA Recent Developments
Table 171. Gilead Sciences Company Details
Table 172. Gilead Sciences Business Overview
Table 173. Gilead Sciences Tumor Treatment Drug Product
Table 174. Gilead Sciences Revenue in Tumor Treatment Drug Business (2019-2024) & (US$ Million)
Table 175. Gilead Sciences Recent Developments
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Treatment Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Tumor Treatment Drug Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Immunotherapy (Biologic Therapy) Features
Figure 6. Hormonal Therapy Features
Figure 7. Others Features
Figure 8. Global Tumor Treatment Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Tumor Treatment Drug Market Share by Application: 2023 VS 2030
Figure 10. Blood Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Gastrointestinal Cancer Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Respiratory/Lung Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Tumor Treatment Drug Report Years Considered
Figure 17. Global Tumor Treatment Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Tumor Treatment Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Tumor Treatment Drug Market Share by Region: 2023 VS 2030
Figure 20. Global Tumor Treatment Drug Market Share by Players in 2023
Figure 21. Global Top Tumor Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Treatment Drug as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Tumor Treatment Drug Revenue in 2023
Figure 23. North America Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Tumor Treatment Drug Market Share by Type (2019-2030)
Figure 25. North America Tumor Treatment Drug Market Share by Application (2019-2030)
Figure 26. North America Tumor Treatment Drug Market Share by Country (2019-2030)
Figure 27. United States Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Tumor Treatment Drug Market Size YoY (2019-2030) & (US$ Million)
Figure 30. Europe Tumor Treatment Drug Market Share by Type (2019-2030)
Figure 31. Europe Tumor Treatment Drug Market Share by Application (2019-2030)
Figure 32. Europe Tumor Treatment Drug Market Share by Country (2019-2030)
Figure 33. Germany Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. China Tumor Treatment Drug Market Size YoY (2019-2030) & (US$ Million)
Figure 40. China Tumor Treatment Drug Market Share by Type (2019-2030)
Figure 41. China Tumor Treatment Drug Market Share by Application (2019-2030)
Figure 42. Asia Tumor Treatment Drug Market Size YoY (2019-2030) & (US$ Million)
Figure 43. Asia Tumor Treatment Drug Market Share by Type (2019-2030)
Figure 44. Asia Tumor Treatment Drug Market Share by Application (2019-2030)
Figure 45. Asia Tumor Treatment Drug Market Share by Region (2019-2030)
Figure 46. Japan Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. South Korea Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. China Taiwan Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. India Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Australia Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Tumor Treatment Drug Market Size YoY (2019-2030) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Tumor Treatment Drug Market Share by Type (2019-2030)
Figure 54. Middle East, Africa, and Latin America Tumor Treatment Drug Market Share by Application (2019-2030)
Figure 55. Middle East, Africa, and Latin America Tumor Treatment Drug Market Share by Country (2019-2030)
Figure 56. Brazil Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Mexico Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Turkey Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Israel Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. GCC Countries Tumor Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 62. Roche Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 63. Celgene Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 64. Novartis Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 66. Johnson & Johnson Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 67. Merck & Co. Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 68. AstraZeneca Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 69. Pfizer Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 70. Amgen Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 71. Eli Lilly Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 72. AbbVie Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 73. Takeda Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 74. Astellas Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 75. Ipsen Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 76. Sanofi Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 77. Bayer Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 78. Biogen Idec Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 79. Teva Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 80. Otsuka Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 81. Eisai Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 82. Merck KGaA Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 83. Gilead Sciences Revenue Growth Rate in Tumor Treatment Drug Business (2019-2024)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies